Sarcoma Alliance for Research Through Collaboration (SARC) Multicenter Trial: A Phase II Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas.
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Perifosine (Primary)
- Indications Chondrosarcoma; Sarcoma
- Focus Therapeutic Use
- 08 Jun 2011 Planned end date changed from 1 Jul 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 08 Jun 2011 Planned end date changed from 1 Jul 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 13 Feb 2009 Planned end date changed from 1 Dec 2008 to 1 Jul 2009, based on information from ClinicalTrials.gov.